Rosen Law Firm Announces Deadline for Checkpoint Therapeutics Securities Class Action - CKPT

NEW YORK, May 14, 2024 (GLOBE NEWSWIRE) – Rosen Law Firm, a renowned global investor rights institution, has issued a reminder to investors who have acquired securities from Checkpoint Therapeutics, Inc. CKPT between March 10, 2021, and December 15, 2023. The firm urges these individuals to secure legal counsel prior to the impending June 4, 2024 deadline tied to a significant securities class-action lawsuit.

Understanding the Allegations

Checkpoint Therapeutics, Inc., operating in the sphere of immuno-oncology biopharmaceuticals, chiefly centers on procuring, developing, and marketing innovative oncological treatments for patients battling solid tumor cancers. With its headquarters situated in the pulsating city of New York, the company has been the focal point of scrutiny regarding potential securities infractions throughout the specified class period.

Important Notice for Shareholders

Shareholders who invested in Checkpoint Therapeutics during the class period and suffered losses are now confronted with the opportunity to participate in the lawsuit. Participation is crucial for shareholders who aspire to recover their investment losses attributed to potential corporate misdeeds or misleading information that impacted CKPT's stock price adversely.

How to Take Action

Investors with stakes in Checkpoint Therapeutics within the defined class period are encouraged to contact legal counsel without delay. The deadline of June 4, 2024, is critical, and failure to act promptly could result in the forfeiture of rights to financial recovery from any future settlements or judgments. The Rosen Law Firm stands ready to provide knowledgeable representation to assert the rights of aggrieved investors and facilitate their inclusion in the ongoing class action.

Rosen, Law, Deadline, Class, Action, Investment, Securities, Reminder, Checkpoint, Therapeutics, CKPT